A protective and agonistic function of IL-12p40 in mycobacterial infection

被引:188
作者
Hölscher, C
Atkinson, RA
Arendse, B
Brown, N
Myburgh, E
Alber, G
Brombacher, F
机构
[1] Univ Cape Town, Dept Immunol, MRC, Unit Immunol Infect Dis, ZA-7925 Cape Town, South Africa
[2] Univ Leipzig, Fac Vet Med, Inst Immunol, D-7010 Leipzig, Germany
关键词
D O I
10.4049/jimmunol.167.12.6957
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
lL-12p35(-/-)p40(-/-) mice are highly susceptible to Mycobacterium bovis bacillus Calmette-Guerin (BCG) or Mycobacterium tuberculosis infection. In this study IL-12p35(-/-) mice, which are able to produce endogenous IL-12p40, cleared M. bovis BCG and showed reduced susceptibility to pulmonary M. tuberculosis infection, which was in striking contrast to the outcome of mycobacterial infection in IL-12p35(-/-)p40(-/-) mice. Resistance in wild-type and IL-12p35(-/-) mice was accompanied by protective granuloma formation and Ag-specific delayed-type hypersensitivity responses, which were impaired in susceptible IL-12p35(-/-)p40(-/-) mice. Furthermore, IL-12p35(-/-) mice, but not IL-12p35(-/-)p40(-/-) mice, mounted Ag-specific Th1 and cytotoxic T cell responses. In vivo therapy with rIL-12p40 homodimer restored the impaired delayed-type hypersensitivity responses in M. bovis MG-infected IL-12p35(-/-)p40(-/-) mice and reverted them to a more resistant phenotype. Together, these results show evidence for a protective and agonistic role of endogenous and exogenous IL-12p40 in mycobacterial infection, which is independent of IL-12p70.
引用
收藏
页码:6957 / 6966
页数:10
相关论文
共 54 条
[11]   AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
CHAN, J ;
TRIEBOLD, KJ ;
DALTON, DK ;
STEWART, TA ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2249-2254
[12]   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-RESTRICTED T-CELLS ARE REQUIRED FOR RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
GOLDSTEIN, MM ;
TRIEBOLD, KJ ;
KOLLER, B ;
BLOOM, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (24) :12013-12017
[13]   CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M-tuberculosis [J].
Freidag, BL ;
Melton, GB ;
Collins, F ;
Klinman, DM ;
Cheever, A ;
Stobie, L ;
Suen, W ;
Seder, RA .
INFECTION AND IMMUNITY, 2000, 68 (05) :2948-2953
[14]   Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo [J].
Gately, MK ;
Carvajal, DM ;
Connaughton, SE ;
Gillessen, S ;
Warrier, RR ;
Kolinsky, KD ;
Wilkinson, VL ;
Dwyer, CM ;
Higgins, GF ;
Podlaski, FJ ;
Faherty, DA ;
Familletti, PC ;
Stern, AS ;
Presky, DH .
INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 :1-12
[15]   INTERLEUKIN-12/T-CELL STIMULATING FACTOR, A CYTOKINE WITH MULTIPLE EFFECTS ON T-HELPER TYPE-1 (TH1) BUT NOT ON TH2 CELLS [J].
GERMANN, T ;
GATELY, MK ;
SCHOENHAUT, DS ;
LOHOFF, M ;
MATTNER, F ;
FISCHER, S ;
JIN, SC ;
SCHMITT, E ;
RUDE, E .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) :1762-1770
[16]   THE IL-12 P40 HOMODIMER AS A SPECIFIC ANTAGONIST OF THE IL-12 HETERODIMER [J].
GERMANN, T ;
RUDE, E ;
MATTNER, F ;
GATELY, MK .
IMMUNOLOGY TODAY, 1995, 16 (10) :500-501
[17]   MOUSE INTERLEUKIN-12 (IL-12) P40 HOMODIMER - A POTENT IL-12 ANTAGONIST [J].
GILLESSEN, S ;
CARVAJAL, D ;
LING, P ;
PODLASKI, FJ ;
STREMLO, DL ;
FAMILLETTI, PC ;
GUBLER, U ;
PRESKY, DH ;
STERN, AS ;
GATELY, MK .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (01) :200-206
[18]  
Ha SJ, 1999, J IMMUNOL, V163, P2902
[19]  
Heinzel FP, 1997, J IMMUNOL, V158, P4381
[20]  
Hölscher C, 1998, INFECT IMMUN, V66, P1208